Cite
HARVARD Citation
Stone, J. et al. (n.d.). OP0131 Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety, and exposure-efficacy analysis from giacta. Annals of the rheumatic diseases. pp. 107-108. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stone, J. et al. (n.d.). OP0131 Optimal dose of tocilizumab for the treatment of giant cell arteritis: efficacy, safety, and exposure-efficacy analysis from giacta. Annals of the rheumatic diseases. pp. 107-108. [Online].